Intuitive Surgical, Inc. (NASDAQ:ISRG) Holdings Increased by Texas Permanent School Fund Corp

Texas Permanent School Fund Corp grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.2% during the first quarter, Holdings Channel reports. The institutional investor owned 72,833 shares of the medical equipment provider’s stock after acquiring an additional 137 shares during the period. Texas Permanent School Fund Corp’s holdings in Intuitive Surgical were worth $29,067,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in ISRG. Provence Wealth Management Group bought a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $276,000. Portside Wealth Group LLC raised its holdings in shares of Intuitive Surgical by 8.2% in the 4th quarter. Portside Wealth Group LLC now owns 816 shares of the medical equipment provider’s stock worth $275,000 after purchasing an additional 62 shares in the last quarter. Sequoia Financial Advisors LLC raised its holdings in shares of Intuitive Surgical by 58.0% in the 4th quarter. Sequoia Financial Advisors LLC now owns 8,315 shares of the medical equipment provider’s stock worth $2,805,000 after purchasing an additional 3,054 shares in the last quarter. Public Employees Retirement System of Ohio raised its holdings in shares of Intuitive Surgical by 5.4% in the 4th quarter. Public Employees Retirement System of Ohio now owns 191,283 shares of the medical equipment provider’s stock worth $64,531,000 after purchasing an additional 9,869 shares in the last quarter. Finally, HCR Wealth Advisors raised its holdings in shares of Intuitive Surgical by 26.3% during the fourth quarter. HCR Wealth Advisors now owns 1,042 shares of the medical equipment provider’s stock valued at $352,000 after acquiring an additional 217 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the stock. Citigroup boosted their price target on shares of Intuitive Surgical from $462.00 to $512.00 and gave the company a “buy” rating in a report on Wednesday. Robert W. Baird cut their price target on shares of Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a report on Friday, April 19th. Piper Sandler boosted their price target on shares of Intuitive Surgical from $435.00 to $490.00 and gave the company an “overweight” rating in a report on Tuesday. Jefferies Financial Group boosted their price target on shares of Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a report on Friday, April 19th. Finally, Evercore ISI boosted their price objective on shares of Intuitive Surgical from $385.00 to $425.00 and gave the company an “in-line” rating in a research report on Tuesday, July 2nd. Six equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $410.32.

Insider Buying and Selling

In related news, EVP Myriam Curet sold 5,318 shares of the company’s stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $370.66, for a total transaction of $1,971,169.88. Following the completion of the sale, the executive vice president now directly owns 298 shares of the company’s stock, valued at approximately $110,456.68. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In related news, EVP Myriam Curet sold 5,318 shares of the company’s stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $370.66, for a total transaction of $1,971,169.88. Following the completion of the transaction, the executive vice president now directly owns 298 shares in the company, valued at approximately $110,456.68. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Alan J. Levy sold 2,000 shares of the company’s stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $370.70, for a total transaction of $741,400.00. Following the transaction, the director now owns 25,319 shares of the company’s stock, valued at $9,385,753.30. The disclosure for this sale can be found here. In the last three months, insiders sold 17,956 shares of company stock valued at $6,927,011. Company insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Down 0.3 %

ISRG stock traded down $1.24 during trading hours on Thursday, hitting $443.50. The company’s stock had a trading volume of 1,818,494 shares, compared to its average volume of 1,508,481. The stock has a 50 day moving average price of $414.51 and a two-hundred day moving average price of $389.28. The company has a market capitalization of $157.31 billion, a PE ratio of 80.28, a price-to-earnings-growth ratio of 5.74 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $449.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.10. The business had revenue of $1.89 billion during the quarter, compared to the consensus estimate of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. Intuitive Surgical’s quarterly revenue was up 11.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.00 EPS. Sell-side analysts expect that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.